Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatma G Amin

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Biomolecular Structure & Dynamics|April 12, 2023
In silico targeting of SARS-CoV-2 spike receptor-binding domain from different variants with chaga mushroom terpenoidsFatma G Amin, Abdo A Elfiky, Aaya M Nassar
Advances in Experimental Medicine and Biology|May 11, 2021
COVID-19 and Cell StressAbdo A Elfiky, Ibrahim M Ibrahim, Fatma G Amin, et al.
RSC Advances|April 24, 2025
Targeting VEGFR-2 in breast cancer: synthesis and <i>in silico</i> and <i>in vitro</i> characterization of quinoxaline-based inhibitorsIbrahim H Eissa, Alaa Elwan, Mustafa A Al-Qadhi, et al.
Future Medicinal Chemistry|May 19, 2026
New chromene derivatives as promising VEGFR-2 inhibitors: combined experimental, DFT, and molecular dynamics approachesEslam B Elkaeed, Hazem Elkady, Walid E Elgammal, et al.
Drug Development Research|May 3, 2026
Structure-Guided Design and Mechanistic Elucidation of New Chromene Derivatives as Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors With Potent Anticancer ActivityHazem Elkady, Walid E Elgammal, Ibrahim H Eissa, et al.
Future Medicinal Chemistry|June 16, 2026
Thiazolidin-based dual Aurora kinase inhibitors with potent anticancer activityWalid E Elgammal, Hazem Elkady, Aisha A Alsfouk, et al.
Bioorganic Chemistry|May 28, 2026
New N-(isoxazol-3-yl)-4-(1,3,4-thiadiazol-3(2H)-yl)benzenesulfonamide derivatives as potent Aurora kinases inhibitors: Design, synthesis and anti-proliferative activityBshra A Alsfouk, Hazem Elkady, Walid E Elgammal, et al.
Natural Product Research|July 3, 2026
Isolation, structure elucidation, and <i>in silico</i> Topoisomerase II inhibition of medicarpins isolated from Alfalfa (<i>Medicago sativa</i>)Ahmed R Hassan, Ahmed Ashour, Marwa Elsbaey, et al.
RSC Advances|May 8, 2025
New nicotinamide-thiadiazol hybrids as VEGFR-2 inhibitors for breast cancer therapy: design, synthesis and <i>in silico</i> and <i>in vitro</i> evaluationWalid E Elgammal, Hazem Elkady, Reda G Yousef, et al.
Molecules (Basel, Switzerland)|November 13, 2021
A Review of Human Coronaviruses' Receptors: The Host-Cell Targets for the Crown Bearing VirusesAaya Nassar, Ibrahim M Ibrahim, Fatma G Amin, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Biomolecular Structure & Dynamics|April 12, 2023
In silico targeting of SARS-CoV-2 spike receptor-binding domain from different variants with chaga mushroom terpenoidsFatma G Amin, Abdo A Elfiky, Aaya M Nassar
Advances in Experimental Medicine and Biology|May 11, 2021
COVID-19 and Cell StressAbdo A Elfiky, Ibrahim M Ibrahim, Fatma G Amin, et al.
RSC Advances|April 24, 2025
Targeting VEGFR-2 in breast cancer: synthesis and <i>in silico</i> and <i>in vitro</i> characterization of quinoxaline-based inhibitorsIbrahim H Eissa, Alaa Elwan, Mustafa A Al-Qadhi, et al.
Future Medicinal Chemistry|May 19, 2026
New chromene derivatives as promising VEGFR-2 inhibitors: combined experimental, DFT, and molecular dynamics approachesEslam B Elkaeed, Hazem Elkady, Walid E Elgammal, et al.
Drug Development Research|May 3, 2026
Structure-Guided Design and Mechanistic Elucidation of New Chromene Derivatives as Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors With Potent Anticancer ActivityHazem Elkady, Walid E Elgammal, Ibrahim H Eissa, et al.
Future Medicinal Chemistry|June 16, 2026
Thiazolidin-based dual Aurora kinase inhibitors with potent anticancer activityWalid E Elgammal, Hazem Elkady, Aisha A Alsfouk, et al.
Bioorganic Chemistry|May 28, 2026
New N-(isoxazol-3-yl)-4-(1,3,4-thiadiazol-3(2H)-yl)benzenesulfonamide derivatives as potent Aurora kinases inhibitors: Design, synthesis and anti-proliferative activityBshra A Alsfouk, Hazem Elkady, Walid E Elgammal, et al.
Natural Product Research|July 3, 2026
Isolation, structure elucidation, and <i>in silico</i> Topoisomerase II inhibition of medicarpins isolated from Alfalfa (<i>Medicago sativa</i>)Ahmed R Hassan, Ahmed Ashour, Marwa Elsbaey, et al.
RSC Advances|May 8, 2025
New nicotinamide-thiadiazol hybrids as VEGFR-2 inhibitors for breast cancer therapy: design, synthesis and <i>in silico</i> and <i>in vitro</i> evaluationWalid E Elgammal, Hazem Elkady, Reda G Yousef, et al.
Molecules (Basel, Switzerland)|November 13, 2021
A Review of Human Coronaviruses' Receptors: The Host-Cell Targets for the Crown Bearing VirusesAaya Nassar, Ibrahim M Ibrahim, Fatma G Amin, et al.
Pageof 2